EP Intravenous Anesthesia in Hysteroscopy

• Status: Not yet recruiting
• Trial end date: 2022-12-31
• Target enrollment: 0
• Participant gender: Female

Summary

Hysteroscopy is a gold standard method for evaluating the uterine cavity and diseases, which is gradually becoming a day-surgery in China. Propofol is one of the most commonly used intravenous anesthetics in clinic for hysteroscopic procedures, however high dose propofol bring some potential clinical safety hazards.In this study, the feasibility and safety of Etomidate combined with propofol(1:2) as improved scheme for hysteroscopic surgery will be evaluated.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: RenJi Hospital
• Treatments: Etomidate; Propofol

Criteria

Inclusion Criteria:

• Elective hysteroscopic surgery;

• intravenous anesthesia;

• normal reading and understanding ability

• volunteer to participate

Exclusion Criteria:

• serious complications such as heart failure, liver failure, pulmonary dysfunction, renal failure, etc.

• predictable difficult airway

• high risk of reflux aspiration

• allergy to propofol or etomidate

• already participated in other clinical trials within three months before admission

• unwilling to cooperate